Alnylam Pharmaceuticals (ALNY) Q3 2020 Earnings

6AugConfirmed
Q4 2019
Q1 2020
Q2 2020
Q3 2020
-2.57
-2.23
-1.9
-1.56

Details

Expected EPS
-1.7
Actual EPS
-1.56
Surprise EPS
0.14
Surprise Percent
+8.24%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.56 per share for Q3 2020.

0 Comments

Share your thoughts